11 results on '"Chen, Chia-Hsiang"'
Search Results
2. Genetic analysis of the DLGAP1 gene as a candidate gene for schizophrenia
- Author
-
Li, Jun-Ming, Lu, Chao-Lin, Cheng, Min-Chih, Luu, Sy-Ueng, Hsu, Shih-Hsin, and Chen, Chia-Hsiang
- Subjects
- *
POSTSYNAPTIC density protein , *GENETICS of schizophrenia , *MENTAL illness , *CHRONIC diseases , *PATHOLOGICAL physiology , *ETIOLOGY of diseases , *ASPARTATE receptors - Abstract
Abstract: Schizophrenia is a severe chronic mental disorder with high genetic components in its etiology. Several studies indicated that synaptic dysfunction is involved in the pathophysiology of schizophrenia. Postsynaptic synapse-associated protein 90/postsynaptic density 95-associated proteins (SAPAPs) constitute a part of the N-methyl-d-aspartate receptor-associated postsynaptic density proteins, and are involved in synapse formation. We hypothesized that genetic variants of the SAPAPs might be associated with schizophrenia. Thus, we systemically sequenced all the exons of the discs, large (Drosophila) homolog-associated protein 1 (DLGAP1) gene that encodes SAPAP1 in a sample of 121 schizophrenic patients and 120 controls from Taiwan. We totally identified six genetic variants, including five known SNPs (rs145691437, rs3786431, rs201567254, rs3745051 and rs11662259) and one rare missense mutation (c.1922A>G) in this sample. SNP- and haplotype-based analyses showed no association of these SNPs with schizophrenia. The c.1922A>G mutation that changes the amino acid lysine to arginine at codon 641 was found in one out of 121 patients, but not in 275 control subjects, suggesting it might be a patient-specific mutation. Nevertheless, bioinformatic analysis showed this mutation does not affect the function of the DLGAP1 gene and appears to be a benign variant. Hence, its relationship with the pathogenesis remains to be investigated. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
3. Genetic and functional analyses of early growth response (EGR) family genes in schizophrenia
- Author
-
Cheng, Min-Chih, Chuang, Yang-An, Lu, Chao-Lin, Chen, Yu-Jung, Luu, Sy-Ueng, Li, Jun-Ming, Hsu, Shih-Hsin, and Chen, Chia-Hsiang
- Subjects
- *
GENETICS of schizophrenia , *CATECHOL-O-methyltransferase , *MENTAL illness , *SINGLE nucleotide polymorphisms , *PHENCYCLIDINE , *RESTRICTION fragment length polymorphisms , *METHYL aspartate receptors , *FUNCTIONAL analysis - Abstract
Abstract: Objective: Early growth response genes (EGR1, 2, 3, and 4) encode a family of nuclear proteins that function as transcriptional regulators. They are involved in the regulation of synaptic plasticity, learning, and memory, and are implicated in the pathogenesis of schizophrenia. Methods: We conducted a genetic association analysis of 14 SNPs selected from the EGR1, 2, 3, and 4 genes of 564 patients with schizophrenia and 564 control subjects. We also conducted Western blot analysis and promoter activity assay to characterize the EGR genes associated with schizophrenia Results: We did not detect a true genetic association of these 14 SNPs with schizophrenia in this sample. However, we observed a nominal over-representation of C/C genotype of rs9990 of EGR2 in female schizophrenia as compared to female control subjects (p=0.012, uncorrected for multiple testing). Further study showed that the average mRNA level of the EGR2 gene in the lymphoblastoid cell lines of female schizophrenia patients was significantly higher than that in female control subjects (p=0.002). We also detected a nominal association of 4 SNPs (rs6747506, rs6718289, rs2229294, and rs3813226) of the EGR4 gene that form strong linkage disequilibrium with schizophrenia in males. Reporter gene assay showed that the haplotype T-A derived from rs6747506 and rs6718289 at the promoter region had significantly reduced promoter activity compared with the haplotype A-G. Conclusion: Our data suggest a tendency of gender-specific association of EGR2 and EGR4 in schizophrenia, with an elevated expression of EGR2 in lympoblastoid cell lines of female schizophrenia patients and a reduced EGR4 gene expression in male schizophrenia patients. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
4. Identification and characterization of three inherited genomic copy number variations associated with familial schizophrenia.
- Author
-
Liao, Hsiao-Mei, Chao, Yu-Lin, Huang, Ai-Ling, Cheng, Min-Chih, Chen, Yann-Jang, Lee, Kuei-Fang, Fang, Jye-Siung, Hsu, Chih-Hao, and Chen, Chia-Hsiang
- Subjects
- *
ETIOLOGY of schizophrenia , *GENETICS of schizophrenia , *DNA copy number variations , *FAMILIAL diseases , *DELETION mutation , *CHROMOSOME duplication , *MEDICAL research - Abstract
Schizophrenia is a complex mental disorder with high degree of genetic influence in its etiology. Several recent studies revealed that copy number variations (CNVs) of genomic DNA contributed significantly to the genetic architecture of sporadic schizophrenia. This study aimed to investigate whether CNVs also contribute to the familial forms of schizophrenia. Using array-based comparative genomic hybridization technology, we searched for pathogenic CNV associated with schizophrenia in a sample of 60 index cases from multiplex schizophrenia families. We detected three inherited CNVs that were associated with schizophrenia in three families, including a microdeletion of ~ 4.4 Mb at chromosome 6q12–q13, a microduplication of ~ 1 Mb at chromosome 18q12.3, and an interstitial duplication of ~ 5 Mb at chromosome 15q11.2–q13.1. Our data indicate that CNVs contribute to the genetic underpinnings of the familial forms of schizophrenia as well as of the sporadic form. As 15q11–13 duplication is a well-known recurrent CNV associated with autism in the literature, the detection of the 15q11.2–q13.1 duplication in our schizophrenia patients provides additional support to other studies reporting that schizophrenia is part of the clinical spectrum of 15q11–q13 duplication syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
5. Genetic and functional analyses of the gene encoding synaptophysin in schizophrenia
- Author
-
Shen, Yu-Chih, Tsai, Ho-Min, Ruan, Jhen-Wei, Liao, Yi-Chu, Chen, Shih-Fen, and Chen, Chia-Hsiang
- Subjects
- *
GENETICS of schizophrenia , *FUNCTIONAL analysis , *GENETIC code , *SYNAPTOPHYSIN , *NEUROTRANSMITTERS , *NEUROPLASTICITY , *GENE expression , *DISEASE susceptibility - Abstract
Abstract: Objectives: Synaptophysin (SYP) has been shown to be critical for regulating neurotransmitter release and synaptic plasticity, a process thought to be disrupted in schizophrenia. In addition, abnormal SYP expression in different brain regions has been linked to this disorder in postmortem brain studies. We investigated the involvement of the SYP gene in the susceptibility to schizophrenia. Methods: We searched for genetic variants in the promoter region, all exons, and both UTR ends of the SYP gene using direct sequencing in a sample of patients with schizophrenia (n=586) and non-psychotic controls (n=576), both being Han Chinese from Taiwan, and conducted an association and functional study. Results: We identified 2 common SNPs (c.*4+271A>G and c.*4+565T>C) in the SYP gene. SNP and haplotype-based analyses displayed no associations with schizophrenia. In addition, we identified 6 rare variants in 7 out of 586 patients, including 1 variant (g.-511T>C) located at the promoter region, 1 synonymous (A104A) and 2 missense variants (G293A and A324T) located at the exonic regions, and 2 variants (c.*31G>A and c.*1001G>T) located at the 3′UTR. No rare variants were found in the control subjects. The results of the reporter gene assay demonstrated the influence of g.-511T>C and c.*1001G>T on the regulatory function of the SYP gene, while that the influence of c.*31G>A may be tolerated. In silico analysis demonstrated the functional relevance of other rare variants. Conclusion: Our study lends support to the hypothesis of multiple rare mutations in schizophrenia, and provides genetic clues that indicate the involvement of SYP in this disorder. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
6. Genetic and functional analysis of the gene encoding neurogranin in schizophrenia
- Author
-
Shen, Yu-Chih, Tsai, Ho-Min, Cheng, Min-Chih, Hsu, Shih-Hsin, Chen, Shih-Fen, and Chen, Chia-Hsiang
- Subjects
- *
GENETICS of schizophrenia , *GENETIC code , *FUNCTIONAL analysis , *ETIOLOGY of diseases , *PATHOLOGICAL physiology , *PROMOTERS (Genetics) - Abstract
Abstract: Objectives: Schizophrenia is a highly heritable disorder, but many aspects of its etiology and pathophysiology remain poorly understood. Recently, a SNP rs12807809 located upstream of the neurogranin (NRGN) gene achieved genome-wide significance in this disorder. Methods: In order to find the causal variants of NRGN gene in schizophrenia, we searched for genetic variants in the promoter region and all the exons (including both UTR ends and rs12807809) using direct sequencing in a sample of patients with schizophrenia (n=346) and non-psychotic controls (n=345), both being Han Chinese from Taiwan, and conducted an association and functional study. Results: We identified 7 common polymorphisms in the NRGN gene. SNP and haplotype-based analyses displayed no associations with schizophrenia. Additionally, we identified 5 rare variants in 6 out of 346 patients, including 3 rare variants located at the promoter region (g.-620A>G, g.-578C>G, and g.-344G>A) and 2 rare variants located at 5′ UTR (c.-74C>G, and c.-41G>A). No rare variants were found in the control subjects. The results of the reporter gene assay demonstrated that the regulatory activity of construct containing g.-620G, g.-578G, g.-344A, c.-74G, and c.-41A was significantly lower as compared to the wild type construct (P<0.01 for g.-578G; P<0.001 for the other constructs). In silico analysis also demonstrated their influences on the regulatory function of NRGN gene. Conclusions: Our study lends support to the hypothesis of multiple rare mutations in schizophrenia, and provides genetic clues that indicate the involvement of NRGN in this disorder. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
7. Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia
- Author
-
Shen, Yu-Chih, Liao, Ding-Lieh, Lu, Chao-Lin, Chen, Jen-Yeu, Liou, Ying-Jay, Chen, Tzu-Ting, and Chen, Chia-Hsiang
- Subjects
- *
GENETICS of schizophrenia , *NUCLEOTIDE sequence , *GLUTAMIC acid , *DOPAMINERGIC neurons , *GENETIC code , *GENETIC mutation , *HUMAN genetic variation - Abstract
Abstract: Objectives: Vesicular glutamate transporters (VGLUT1-3) package glutamate into vesicles in the presynaptic terminal and regulate the release of glutamate. In mesencephalic dopamine neuron culture, the majority of isolated dopamine neurons express VGLUT2, but not VGLUT1 or 3, have been demonstrated. As related to the dysregulated glutamatergic hypothesis of schizophrenia, the gene encoding VGLUT2 is the most plausible candidate involved in the pathogenesis of this illness. Methods: We searched for genetic variants in the promoter region and 12 exons (including UTR ends) of the VGLUT2 gene using direct sequencing in a sample of Han Chinese schizophrenic patients (n =375) and non-psychotic controls (n =366) from Taiwan, and conducted a case-control association study. Results: We identified 8 common SNPs in the VGLUT2 gene. SNP and haplotype-based analyses showed no association with schizophrenia. Besides, we identified 9 rare variants in 13 out of 375 patients, including 3 variants located at the promoter region, 2 synonymous variants located at protein coding regions, and 4 variants located at UTR ends. No rare variants were found in the control subjects. Collectively, these rare variants were significantly overrepresented in the patient group (3.5% versus 0, p value of Fisher''s exact test=2.3×10− 5), suggesting they may contribute to the pathogenesis of schizophrenia. Conclusion: Although the functional significance of these rare variants remains to be characterized, our study may lend support to the multiple rare mutations hypothesis of schizophrenia, and may provide genetic clues to indicate the involvement of the glutamate transmission pathway in the pathogenesis of schizophrenia. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
8. Resequencing and association study of vesicular glutamate transporter 1 gene (VGLUT1) with schizophrenia
- Author
-
Shen, Yu-Chih, Liao, Ding-Lieh, Chen, Jen-Yeu, Wang, Ying-Chieh, Lai, I-Ching, Liou, Ying-Jay, Chen, Yu-Jun, Luu, Sy-Ueng, and Chen, Chia-Hsiang
- Subjects
- *
GENETICS of schizophrenia , *PEOPLE with schizophrenia , *GLUTAMIC acid , *NEURAL transmission , *GENETIC mutation , *CASE-control method , *GENETIC polymorphisms , *GENETICS of disease susceptibility - Abstract
Abstract: Dysregulation of glutamate neurotransmission is implicated in the pathphysiology of schizophrenia. Vesicular glutamate transporters (VGLUTs) package glutamate into vesicles in the presynaptic terminal and regulate the release of glutamate. Abnormal VGLUT1 expression has been linked to schizophrenia in postmortem brain studies. The purpose of this study was to investigate the involvement of the human VGLUT1 in the susceptibility to schizophrenia. In this study, we searched for genetic variants in the putative core promoter region and 12 exons (including UTR ends) of the VGLUT1 gene using direct sequencing in a sample of Han Chinese schizophrenic patients (n =376) and non-psychotic controls (n =368) from Taiwan, and conducted a case-control association study. We identified two common SNPs (g.-248G>C (ss159695612) and c.2697C>A (rs1043558)) in the VGLUT1 gene. No differences in the allele and genotype frequencies were detected between the patients and control subjects. Besides, we identified eight patient-specific rare variants in 16 out of 376 patients, including two variants (g.-296A>G (ss159695611) and g.-32Cv>T (ss159695613)) at the core promoter region and 5′UTR, two missense variants (L516M (ss159695617) and P551S (ss159695618)) and three silent variants (E24E (ss159695614), L118L (ss159695615), and P133P (ss159695616)) at protein-coding regions, and one variant (c.2201G>A (ss159695619)) at the 3′UTR. No rare variants were found in 368 control subjects (4.3% versus 0, P =1.5×10−5). Although the functional significance of these rare variants remains to be characterized, our study may lend support to the multiple rare mutation hypothesis of schizophrenia, and may provide genetic clues to indicate the involvement of the glutamate transmission pathway in the pathogenesis of schizophrenia. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
9. Exomic sequencing of the glutamate receptor, ionotropic, N-methyl-d-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia
- Author
-
Shen, Yu-Chih, Liao, Ding-Lieh, Chen, Jen-Yeu, Wang, Ying-Chieh, Lai, I-Ching, Liou, Ying-Jay, Chen, Yu-Jun, Luu, Sy-Ueng, and Chen, Chia-Hsiang
- Subjects
- *
GLUTAMIC acid , *AMINO acid sequence , *NEUROTRANSMITTER receptors , *METHYL aspartate , *GENETICS of schizophrenia , *PATHOLOGICAL physiology , *PEOPLE with schizophrenia , *GENETIC mutation , *POLYMERASE chain reaction , *GENETIC polymorphisms - Abstract
Abstract: Background: Growing evidence suggests that dysregulation of N-methyl-d-aspartate receptor (NMDAR)-mediated glutamate neurotransmission may be involved in the pathophysiology of schizophrenia. The NMDAR is a heteromeric protein complex consisting of subunits from three subfamilies (NR1, NR2A, 2B, 2C, 2D and NR3A, 3B). The unique ability of NR3A to modulate the NMDAR function makes it an attractive candidate gene of schizophrenia. The purpose of this study was to investigate the involvement of the gene encoding the human NR3A subunit (GRIN3A) in the liability to schizophrenia. Methods: We searched for genetic variants in the putative core promoter region and all the exons (including UTR ends) of the GRIN3A gene in 333 Han Chinese patients with schizophrenia and 369 control subjects from Taiwan using direct polymerase chain reaction (PCR) autosequencing, and assessed their association with schizophrenia. Results: We identified 22 single nucleotide polymorphisms (SNPs) in the GRIN3A gene in this sample. SNP- and haplotype-based analyses showed no association of these 22 SNPs with schizophrenia. Nevertheless, we identified two missense mutations (D133N and Q1091H), one nonsense mutation (R1024X), and two synonymous mutations (Y873Y and E889E) of the GRIN3A gene in 6 out of 333 (1.8%) patients, while no rare mutations were found in 369 control subjects (p =0.011, Fisher''s exact test, one-tailed). In silico analysis showed that the R1024X and Q1091H mutations are possibly damaging. Conclusions: Although the functional significance of these mutations remains to be characterized, our study indicates that rare mutations in the GRIN3A gene may contribute to the pathogenesis of schizophrenia in certain patients. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
10. Association study of HLA-A gene and schizophrenia in Han Chinese from Taiwan
- Author
-
Chao, Yu-Lin, Shen, Yu-Chih, Liao, Ding-Lieh, Chen, Jen-Yeu, Wang, Ying-Chieh, Lai, I-Ching, Liou, Ying-Jay, and Chen, Chia-Hsiang
- Subjects
- *
GENETICS of schizophrenia , *HLA histocompatibility antigens , *IMMUNOREGULATION , *MEDICAL literature , *CHLAMYDIA infections , *GENETIC polymorphisms , *CHINESE people , *DISEASES - Abstract
Abstract: Dysregulation of the immune response has been proposed as a precipitating factor of schizophrenia, and human leukocyte antigens (HLA) play a critical role in regulating the cascade of immunological reaction. Hence, many studies have investigated the relationship between the HLA system and schizophrenia. HLA is a complex gene family that contains several highly polymorphic genes, while the HLA-A gene is the most often studied gene to be associated with schizophrenia in the literature. A recent study reported that the interaction of the HLA-A10 allele and Chlamydial infection was highly associated with schizophrenia in a German population, which prompted us to investigate whether the HLA-A gene was also associated with schizophrenia in our population. Using a sequencing-based HLA typing method, we determined the HLA-A genotypes in 377 Han Chinese patients with schizophrenia (214 males, 163 females) and 321 non-psychotic Han Chinese control subjects (164 males, 157 females) from Taiwan. In total, 26 DNA-defined HLA-A alleles were identified in this sample. However, no significant differences of these allelic frequencies were found between the patients and the control subjects, suggesting that the HLA-A gene was unlikely a major risk factor of schizophrenia in this sample. As different populations have different HLA polymorphisms, an examination of the relationship of other HLA genes and schizophrenia in our population, with a larger sample size, is warranted in the future. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
11. Mutation analysis of DARPP-32 as a candidate gene for schizophrenia
- Author
-
Li, Chen-Hao, Liao, Hsiao-Mei, Hung, Tsai-Wei, and Chen, Chia-Hsiang
- Subjects
- *
GENETICS of schizophrenia , *GENETIC mutation , *GENES , *TRANSCRIPTION factors , *ALLELES , *AMINO acids , *BINDING sites , *CYCLIC adenylic acid , *DISEASE susceptibility , *DNA , *DNA probes , *GENETIC polymorphisms , *POLYMERASE chain reaction , *SCHIZOPHRENIA , *SEQUENCE analysis , *GENOTYPES - Abstract
Abstract: Dopamine- and cAMP-regulated phosphoprotein of relative molecular mass 32kDa (DARPP-32) plays a pivotal role in the signal transduction of several neurotransmitters and neuromodulators that are implicated in the pathophysiology of a variety of neuropsychiatric disorders. A postmortem study reported a significantly reduced DARPP-32 expression in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia, suggesting possible involvement of DARPP-32 in the pathophysiology of schizophrenia. Hence, DARPP-32 was considered as a candidate gene for schizophrenia in this study. We first systemically searched for mutations in the DARPP-32 gene in 50 Han Chinese patients with schizophrenia from Taiwan. Five molecular variants were identified, including a C-to-G substitution (g.-2036C>G) in the putative core promoter that obliterated a predictive AP-2 transcription factor binding site, a G deletion in the untranslated exon 2 (g.1238delG), a G-to-A and an A-to-G substitutions in intron 2 (IVS2+31G>A) and intron 6 (IVS6+32A>G), respectively, and a three-base pair deletion of AGA in exon 6 that resulted in deletion of a glutamate at codon 135 (E135del). Further SNP- and haplotype-based association study in 249 patients and 273 control subjects, however, did not detect association of these markers with schizophrenia. Hence, our results suggest that the reduced DARPP-32 protein in patients with schizophrenia is unlikely caused by mutations in the DARPP-32 gene itself and the DARPP-32 gene is also unlikely a major susceptibility gene for schizophrenia. Nevertheless, the identification of these molecular variants should help the study of gene regulation and structure–function relationship of DARPP-32, and the association study of DARPP-32 gene with other neuropsychiatric disorders. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.